H1-receptor
4 drugs3
approved indications
4
Approved Drugs
4
Companies
5
Indications
0
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (4 companies)
✓ All 4 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (5 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
Dr. Reddy's 1 drug
JDP 1 drug
SOMERSET THERAPS LLC 1 drug
By Therapeutic Area
Other 4 drugs
Drugs by Company PRO
Dr. Reddy's 1 drug
JDP 1 drug
SOMERSET THERAPS LLC 1 drug
BAUSCH AND LOMB INC 1 drug
By Therapeutic Area
Other 4 drugs
DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR, QUZYTTIR, BEPOTASTINE BESILATE, BEPREVE
Indications Treated
UrticariaAllergic ConjunctivitisSeasonal Allergic RhinitisPerennial Allergic RhinitisChronic Idiopathic Urticaria
All Drugs Targeting H1-receptor
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR | Dr. Reddy's | 2011 | 3 | |
| QUZYTTIR | JDP | 2019 | 1 | |
| BEPOTASTINE BESILATE | SOMERSET THERAPS LLC | 2019 | 1 | |
| BEPREVE | BAUSCH AND LOMB INC | 2009 | 1 |